Aging, Cerebral Amyloid Angiopathy, and Amyloid Beta Clearance

Principal Investigator
Jorge Ghiso, PhD
New York University Grossman School of Medicine
New York, NY, USA
About the Research Project
Program
Award Type
Standard
Award Amount
$250,000
Active Dates
July 01, 2015 - June 30, 2019
Grant ID
A2015275S
Acknowledgement
Co-Principal Investigator(s)
Agueda Rostagno, PhD, New York University Grossman School of Medicine
Goals
Alzheimer’s disease, the most common form of dementia, is characterized by fibrillar deposits of amyloid beta (Aβ) protein in brain tissue and cerebral blood vessels. The complex molecular mechanisms involved in the formation and accumulation of these deposits are not well understood; however, the brain’s failure to remove Aβ is increasingly recognized as a central element in the disease pathogenesis. Our preliminary data indicate that the action of brain enzymes and impaired clearance of the resulting degradation fragments via the blood and cerebrospinal fluid should not be overlooked as crucial contributors. The central focus of this project is how brain Aβ removal is additionally influenced by aging and by the dysfunction of the cerebral microvasculature. Using state of the art methodologies and genetically engineered mouse models with severely compromised cerebral blood vessels, this project will provide a better understanding how the brain degrades and removes Aβ in health and disease, an approach that will likely identify new targets for pharmacologic intervention.
Summary
Grantee institution at the time of this grant: NYU Langone Health
Grants
Related Grants
Alzheimer's Disease Research
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Olav Andersen, PhD
Regulatory Mechanisms Underlying Endosomal Targeting of SORL1
Active Dates
January 01, 2025 - December 31, 2026

Principal Investigator
Olav Andersen, PhD
Alzheimer's Disease Research
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027
Principal Investigator
Frances Wiseman, PhD
The Role of DYRK1A in Altered Microglia Biology in a Cellular Model of Alzheimer’s Disease in Down Syndrome
Active Dates
January 01, 2025 - December 31, 2027

Principal Investigator
Frances Wiseman, PhD
Alzheimer's Disease Research
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD
Synergistic Effects of Biological Sex and Sleep Loss in an AD Mouse Model
Active Dates
January 01, 2025 - December 31, 2026
Principal Investigator
Mallar Chakravarty, PhD